Report Highlights
The global life science tools and diagnostics market should reach $87.3 billion by 2025 from $82.2 billion in 2020 at a compound annual growth rate (CAGR) of 7.7% for the forecast period of 2019 to 2025.
Report Includes
- 95 data tables and 21 additional tables
- An overview of the global market for life science tools and diagnostics
- Estimation of the market size and analyses of market trends, with data from 2018, 2019, 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Discussion on how scientific trends, government policies, and the economy in general affect life science tools and diagnostics market and how this industry is different from the pharmaceutical and drug discovery industry
- Assessment of existing products and identification of new potential markets for novel products and assay development
- Detailed description about COVID-19, including disease progression, symptoms and treatment options and impact analysis of COVID-19 on entire life science industry as well as on life science tools and diagnostics industry
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size, market forecast, and technological advancements within the industry
- Comprehensive company profiles of the leading players, including Abbott Laboratories, Bio-Rad Laboratories, General Electric Co., Merck & Co. Inc., Qiagen NV, and Siemens Healthcare AG
Report Scope
The current report provides a detailed look at the life science tools and diagnostics market. This report also highlights the current and future market potential of life science tools and diagnostics, along with a detailed analysis of the competitive environment, regulatory scenario, technological advances, and drivers, restraints, opportunities and trends in the market. The report also covers market projections to 2025. The report details the market share of life science tools and diagnostics.
By geographical region, the market has been segregated into North America, Europe, Asia-Pacific, and the Rest of the world (RoW). The North America region includes the U.S., Canada and Mexico; Europe includes Germany, the U.K., France, Italy, Spain and the Rest of Europe. The Asia-Pacific region includes China, India, Japan, and the Rest of Asia-Pacific. For market estimates, data has been provided for 2018 as the base year, 2019 and forecast for 2025.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- AI Impact on Specialty Water Treatment Chemicals Market - BCC Pulse Report (AIT086A)
- Data Center Networking Technologies: Global Markets (IFT103C)
- Global GLP-1 Analogues Market (PHM289A)
- Elastomers: Applications and Global Markets (CHM056E)
- Biofuels: Global Markets (EGY064F)
Related Reports
Proteomics: Technologies and Global Markets
The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.
Biosimilars: Global Markets
The global biosimilars market was valued at $23.8 billion in 2023. The market is expected to grow from $28.5 billion in 2024 to $69.2 billion by 2029, at a compound annual growth rate (CAGR) of 19.4% from 2024 through 2029.
Global Markets for Media, Sera and Reagents in Biotechnology
The global market for media, sera and reagents in biotechnology is expected to grow from $6.3 billion in 2024 and is projected to reach $9.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.1% during the forecast period of 2024 to 2029.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Protein Expression: Global Markets
The global market for protein expression is estimated to grow from $4.7 billion in 2025 to reach $7.9 billion by 2030, at a compound annual growth rate (CAGR) of 10.9% from 2025 through 2030.
Biological Therapies for Cancer: Technologies and Global Markets
The global biological therapies market for cancer is expected to grow from $157 billion in 2025 and is projected to reach $225 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2025 to 2030.
Cell Therapy Processing: Global Markets and Technologies
The global market for cell therapy processing is estimated to grow from $2.7 billion in 2025 to reach $7.1 billion by 2030, at a compound annual growth rate (CAGR) 21.4% from 2025 to 2030.
Fusion Proteins: Global Market
The global market for fusion proteins is expected to grow from $36.3 billion in 2025 to reach $64.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.3% from 2025 to 2030.
Separation Systems for Commercial Biotechnology
The global market for bioseparation systems is expected to grow from $32.5 billion in 2025 and is projected to reach $45.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2025 to 2030.
Top Trending Reports
Contract Manufacturing of Medical Devices: Global Markets
The global market for contract manufacturing of medical devices is estimated to grow from $96.4 billion in 2025 to reach $155.2 billion by 2030, at a compound annual growth rate (CAGR) of 10% from 2025 to 2030.
Bioprocess Filtration: Global Markets
The global market for bioprocess filtration is estimated to grow from $8.4 billion in 2025 to reach $15.6 billion by 2030, at a compound annual growth rate (CAGR) of 13.1% from 2025 through 2030.
Global Data Center Market
The global market for data centers is expected to grow from $418.2 billion in 2025 and is projected to reach $691.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.6% during the forecast period of 2025 to 2030.
Biological Therapies for Cancer: Technologies and Global Markets
The global biological therapies market for cancer is expected to grow from $157 billion in 2025 and is projected to reach $225 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2025 to 2030.
Immunotherapy Drugs: Global Markets
The global immunotherapy drugs market is expected to grow from $260.7 billion in 2025 and is projected to reach $467.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% during the forecast period of 2025 to 2030.
Report Highlights
The global market for life sciences tools and reagents reached $45.9 billion in 2014 and $48.2 billion in 2015. The market should reach $58.0 billion by 2020, growing at a compound annual growth rate (CAGR) of 3.8% from 2015 to 2020.
Report Includes
- An overview of the global market for life science tools and reagents.
- Analyses of global market trends, with data from 2013 and 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020.
- Identification of existing products as well as new potential markets for novel products and assay development.
- Discussion of how scientific trends, government policies, and the economy in general affect this industrial market as compared to pharmaceutical and drug discovery ventures; for example, the launches of new reagents or products is not affected by strict FDA guidelines.
- Examination of drivers and challenges in each segment of the industry.
- Relevant patent analysis.
- Comprehensive company profiles of major players in the market.
Report Highlights
The global market for life science tools and reagents reached $47.8 billion in 2012. This figure is expected to increase to $51.3 billion in 2013 and $77.6 billion in 2018, with a projected five-year compound annual growth rate (CAGR) of 8.6%.
Report Includes
- An overview of the global market for life science tools and reagents.
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Identification of existing products as well as new potential markets for novel products and assay development.
- Discussion of how scientific trends, government policies, and the economy in general affect this industrial market as compared to pharmaceutical and drug discovery ventures; for example, the launches of new reagents or products is not affected by strict FDA guidelines.
- Examination of drivers and challenges in each segment of the industry.
- Patent analysis.
- Comprehensive company profiles of major players in the market.
Report Highlights
The life science tools market has shown steady growth over the last couple of years despite the economic downturn. This market is currently valued at more than $42 billion and is projected to increase at compound annual growth rate (CAGR) of 13.6% to reach approximately $81 billion in 2016.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More